Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Renal Failure: Dose Adjustments

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

Dialysis

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...

Acute Kidney Injury I: Introduction

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

High-Statistics Measurement of the Cosmic-Ray Electron Spectrum with H.E.S.S.

Physical review letters·2024

Same author

Acceleration and transport of relativistic electrons in the jets of the microquasar SS 433.

Science (New York, N.Y.)·2024

Same author

Reusable laryngoscope blades: a more eco-responsible and cost-effective alternative.

Anaesthesia, critical care & pain medicine·2023

Same author

Patient satisfaction after distal upper limb surgery under WALANT versus axillary block: A propensity-matched comparative cohort study.

Hand surgery & rehabilitation·2022

Same author

Ecoresponsible actions in operating rooms: A health ecological and economic evaluation.

International journal of surgery (London, England)·2022

Same author

Time-resolved hadronic particle acceleration in the recurrent nova RS Ophiuchi.

Science (New York, N.Y.)·2022

Search research articles

Related Experiment Video

Updated: May 31, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on: March 11, 2016

[Sugammadex and renal failure: a case report].

M Briere¹, C Boisson, P Cuvillon

¹Département D'anesthésie-Réanimation, Douleur, Urgences, CHU de Nîmes, place du Professeur-Debré, 30029 Nîmes Cedex 09, France. mathieubriere@laposte.net

Annales Francaises D'Anesthesie Et De Reanimation

|July 2, 2011

Summary

Sugammadex demonstrated delayed antagonism of rocuronium-induced neuromuscular blockade in a patient with acute renal failure. Multiple doses were required, highlighting considerations for sugammadex use in renal impairment.

More Related Videos

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

Direct Drug Delivery to Kidney via the Renal Artery

Direct Drug Delivery to Kidney via the Renal Artery

Published on: April 17, 2021

Related Experiment Videos

Last Updated: May 31, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on: March 11, 2016

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

Direct Drug Delivery to Kidney via the Renal Artery

Direct Drug Delivery to Kidney via the Renal Artery

Published on: April 17, 2021

Area of Science:

Anesthesiology
Pharmacology
Nephrology

Background:

Neuromuscular blocking agents are crucial in anesthesia for facilitating endotracheal intubation and surgical procedures.
Rocuronium, a non-depolarizing neuromuscular blocker, is frequently used for rapid sequence induction.
Sugammadex is a reversal agent for rocuronium, but its use in renal impairment requires careful consideration.

Observation:

A patient with acute renal failure and hyperkalemia underwent rapid sequence induction using rocuronium due to contraindication of succinylcholine.
Delayed and incomplete antagonism of rocuronium-induced deep neuromuscular blockade was observed after sugammadex administration.
A cumulative dose of 12 mg/kg sugammadex was administered over 30 minutes, requiring three separate injections.

Findings:

Sugammadex reversal of rocuronium was significantly delayed in the presence of acute renal failure.
The pharmacokinetic profile of sugammadex may be altered in patients with impaired renal function, affecting its efficacy.
This case highlights a potential challenge in sugammadex's utility for neuromuscular blockade reversal in specific patient populations.

Implications:

Clinicians should exercise caution when using sugammadex for rocuronium reversal in patients with acute renal failure.
Further research is warranted to elucidate the impact of renal impairment on sugammadex pharmacokinetics and pharmacodynamics.
Alternative strategies or dose adjustments for sugammadex may be necessary in patients with compromised renal function to ensure adequate reversal of neuromuscular blockade.